Promethazine and Nuplazid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Promethazine (promethazine hydrochloride) and Nuplazid (pimavanserin tartrate). Common drug interactions include renal failure among females and confusional state among males.

The phase IV clinical study analyzes what interactions people have when they take Promethazine and Nuplazid. It is created by eHealthMe based on reports of 60 people who take the same drugs from the FDA, and is updated regularly.

What is Promethazine?

Promethazine has active ingredients of promethazine hydrochloride. It is often used in nausea. eHealthMe is studying from 32,300 Promethazine users. Check the latest studies of Promethazine.

What is Nuplazid?

Nuplazid has active ingredients of pimavanserin tartrate. eHealthMe is studying from 47,103 Nuplazid users. Check the latest studies of Nuplazid.



On Jul, 27, 2026

60 people who take Promethazine and Nuplazid together, and have interactions are studied.

Promethazine and Nuplazid drug interactions.

What are the common drug interactions of Promethazine and Nuplazid, by gender? *:

female:

  1. Renal failure (kidney dysfunction)
  2. Respiratory disorder (respiratory disease)
  3. Swollen tongue (swelling of tongue)
  4. Hallucination (an experience involving the perception of something not present)
  5. Back pain
  6. Delusion (a false belief or opinion)
  7. Drug ineffective
  8. Dysphagia (a condition in which swallowing is difficult or painful)
  9. Dyspnoea (difficult or laboured respiration)
  10. Therapeutic response unexpected

male:

  1. Confusional state
  2. Hallucination (an experience involving the perception of something not present)
  3. Unresponsive to stimuli
  4. Urinary tract infection bacterial
  5. Fall
  6. Muscular weakness (muscle weakness)
  7. Oedema peripheral (superficial swelling)
  8. Peripheral swelling
  9. Tremor (trembling or shaking movements in one or more parts of your body)
  10. Dysphagia (a condition in which swallowing is difficult or painful)

What are the common drug interactions of Promethazine and Nuplazid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Eye swelling
  2. Somnolence (a state of near-sleep, a strong desire for sleep)
  3. Nonspecific reaction (unspecified reaction)
  4. Back pain
  5. Blood glucose decreased
  6. Diarrhoea
  7. Dyskinesia (abnormality or impairment of voluntary movement)
  8. Joint stiffness
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

50-59:

  1. Dyspnoea (difficult or laboured respiration)
  2. Heart rate increased
  3. Nephrolithiasis (calculi in the kidneys)
  4. Swelling

60+:

  1. Hallucination (an experience involving the perception of something not present)
  2. Death
  3. Confusional state
  4. Dizziness
  5. Fatigue (feeling of tiredness)
  6. Ill-defined disorder
  7. Surgery
  8. Diarrhoea
  9. Rash pruritic (redness with itching)
  10. Scratch

What are the existing conditions these people have? *

  1. Parkinson's Disease: 35 people, 58.33%
  2. Hallucinations (sensations that appear real but are created by your mind): 31 people, 51.67%
  3. Delusion (a false belief or opinion): 26 people, 43.33%
  4. Dementia With Lewy Bodies (progressive degenerative disease or syndrome of the brain): 6 people, 10.00%
  5. Pain: 4 people, 6.67%
  6. Hallucination, Auditory (perceiving sounds without auditory stimulus): 4 people, 6.67%
  7. Dementia (madness): 4 people, 6.67%
  8. Urinary Tract Infection: 3 people, 5.00%
  9. Nausea And Vomiting: 3 people, 5.00%
  10. Headache (pain in head): 3 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Promethazine and Nuplazid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Promethazine and Nuplazid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Promethazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nuplazid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Promethazine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nuplazid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on promethazine hydrochloride and pimavanserin tartrate (the active ingredients of Promethazine and Nuplazid, respectively), and Promethazine and Nuplazid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: